Wei-Fen Chen

  • Citations Per Year
Learn More
BACKGROUND/PURPOSE Explaining the risks and benefits of recombinant tissue-plasminogen activator (rtPA) to eligible patients with acute ischemic stroke (AIS) within a few minutes is important but difficult. We examined whether a new thrombolysis program can decrease the door-to-needle (DTN) time when treating patients with AIS. METHODS A new rtPA(More)
  • 1